Literature DB >> 11293392

Statin-fibrate combinations in patients with combined hyperlipedemia.

V G Athyros, A A Papageorgiou, A G Kontopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11293392     DOI： 10.1016/s0021-9150(00)00726-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  4 in total

1.  Statins and the risk of rhabdomyolysis.

Authors:  R S Rosenson
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

2.  Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

3.  Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action.

Authors:  Vasilios Gabriel Athyros; Michael Doumas; Asterios Karagiannis
Journal:  Indian Heart J       Date:  2016-03-10

Review 4.  Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review.

Authors:  Konstantinos Tziomalos; Vasilios G Athyros
Journal:  Int J Nanomedicine       Date:  2006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.